These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
118 related articles for article (PubMed ID: 4058272)
21. Late phase of liver restoration following partial hepatectomy in phenobarbital-treated rats. II. Effect of phenobarbital on aspartate aminotransferase, alanine aminotransferase, glutamate dehydrogenase, and UDP-glucuronyltransferase activity. Schweiger H Res Exp Med (Berl); 1983; 182(1):27-32. PubMed ID: 6407078 [TBL] [Abstract][Full Text] [Related]
22. Influence of amphotericin B treatment duration of hepatic microsomal enzyme function in rats. Inselmann G; Voss V; Kunigk F; Heidemann H Pharmacology; 1997 Aug; 55(2):87-94. PubMed ID: 9323308 [TBL] [Abstract][Full Text] [Related]
23. Effect of renal failure and bis(2-ethylhexyl) phthalate pretreatment on the disposition and metabolism of antipyrine in the rat. Pollack GM; Shen DD J Pharm Sci; 1984 Jan; 73(1):29-33. PubMed ID: 6694077 [TBL] [Abstract][Full Text] [Related]
24. Metronidazole and antipyrine metabolism in the rat: clearance determination from one saliva sample. Loft S; Nielsen AJ; Borg BE; Poulsen HE Xenobiotica; 1991 Jan; 21(1):33-46. PubMed ID: 2003365 [TBL] [Abstract][Full Text] [Related]
25. Microsomal metabolism of antipyrine in rats treated with antineoplastic drugs. Slørdal L; Høyem-Johansen T; Aarbakke J Pharmacology; 1983; 26(2):95-9. PubMed ID: 6844394 [TBL] [Abstract][Full Text] [Related]
26. Sex difference in antipyrine 3-hydroxylation. An in vivo-in vitro correlation of antipyrine metabolism in two rat strains. Buters JT; Reichen J Biochem Pharmacol; 1990 Aug; 40(4):771-7. PubMed ID: 2386545 [TBL] [Abstract][Full Text] [Related]
27. The capacity of urea-N synthesis as a quantitative measure of the liver mass in rats. Hansen BA; Poulsen HE J Hepatol; 1986; 2(3):468-74. PubMed ID: 3722794 [TBL] [Abstract][Full Text] [Related]
28. Antipyrine clearance in comparison to conventional liver function tests in hepatitis C virus patients. Mahmoud M; Abdel-Kader R; Hassanein M; Saleh S; Botros S Eur J Pharmacol; 2007 Aug; 569(3):222-7. PubMed ID: 17628532 [TBL] [Abstract][Full Text] [Related]
29. Down-regulation of cytochrome P450 proteins and its activities by Shiga-like toxin II from Escherichia coli O157:H7. Kitaichi K; Nakayama H; Ueyama J; Nadai M; Baba K; Takagi K; Takagi K; Ohta M; Hasegawa T Biochem Pharmacol; 2004 Apr; 67(8):1427-35. PubMed ID: 15041460 [TBL] [Abstract][Full Text] [Related]
30. Dual effect of erythropoietin on liver protection and regeneration after subtotal hepatectomy in rats. Greif F; Ben-Ari Z; Taya R; Pappo O; Kurtzwald E; Cheporko Y; Ravid A; Hochhauser E Liver Transpl; 2010 May; 16(5):631-8. PubMed ID: 20440772 [TBL] [Abstract][Full Text] [Related]
31. Correlation between antipyrine clearance and cytochrome P-450 level after phenobarbital induction in rat. Chang SL; Nelson SD; Levy RH Drug Metab Dispos; 1984; 12(1):139-41. PubMed ID: 6141905 [No Abstract] [Full Text] [Related]
32. Correlations between cytochrome P-450 and oxidative metabolism of benzo[a]pyrene and 7-ethoxycoumarin in human liver in vitro and antipyrine elimination in vivo. Pelkonen O; Sotaniemi E; Tokola O; Ahokas JT Drug Metab Dispos; 1980; 8(4):218-22. PubMed ID: 6105054 [TBL] [Abstract][Full Text] [Related]
33. The effect of indomethacin on hepatic drug-oxidizing capacity in the rat: trimethadione and antipyrine metabolism as an indicator. Tanaka E; Kobayashi S; Aramphongphan A; Kurata N; Oguchi K; Kuroiwa Y; Yasuhara H J Pharmacobiodyn; 1985 Sep; 8(9):773-9. PubMed ID: 4087137 [TBL] [Abstract][Full Text] [Related]
34. Hepatic heme metabolism and cytochrome P450 in cirrhotic rat liver. Farrell GC; Zaluzny L Gastroenterology; 1985 Jul; 89(1):172-9. PubMed ID: 4007401 [TBL] [Abstract][Full Text] [Related]
35. Influence of partial hepatectomy in dogs on trimethadione metabolism and microsomal monooxygenases. Tanaka E; Osada A; Ishikawa A; Nakamura T; Momose Y; Mikami T; Fukao K; Horie T Xenobiotica; 1995 Dec; 25(12):1301-10. PubMed ID: 8719906 [TBL] [Abstract][Full Text] [Related]
36. Characterization of antipyrine autoinduction in the rat utilizing a new microsampling technique for serial blood sample collections. Chang SL; Emmick K; Wedlund PJ J Pharm Sci; 1986 May; 75(5):456-8. PubMed ID: 3735083 [TBL] [Abstract][Full Text] [Related]
37. Influence of 9-hydroxyellipticine and 3-methylcholanthrene treatment on antipyrine metabolite formation in rats in vivo. Teunissen MW; Joeres RP; Vermeulen NP; Breimer DD Xenobiotica; 1983 Apr; 13(4):223-31. PubMed ID: 6624137 [TBL] [Abstract][Full Text] [Related]
38. Intravenous epoprostenol sodium does not increase hepatic microsomal enzyme activity in rats. Carlton LD; Schmith VD; Brouwer KL Prostaglandins; 1995; 50(5-6):341-7. PubMed ID: 8838243 [TBL] [Abstract][Full Text] [Related]
39. Antipyrine clearance and metabolite formation: the influence of liver volume and smoking. Spoelstra P; Teunissen MW; Janssens AR; Weeda B; van Duijn W; Koch CW; Breimer DD Eur J Clin Invest; 1986 Aug; 16(4):321-7. PubMed ID: 3093244 [TBL] [Abstract][Full Text] [Related]
40. Effects of flumethrin on hepatic drug-metabolizing enzymes and antipyrine disposition in rats. Anadón A; Martinez-Larrañaga MR; Diaz MJ; Bringas P; Fernandez MC; Martinez MA; Fernandez-Cruz ML Toxicol Appl Pharmacol; 1995 May; 132(1):14-8. PubMed ID: 7747277 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]